Dark Forest Capital Management LP Purchases Shares of 53,384 Henry Schein, Inc. $HSIC

Key Points

• Dark Forest Capital Management LP has acquired 53,384 shares of Henry Schein, Inc., worth approximately $3.66 million, marking a significant new position in the 1st quarter.
• Henry Schein's recent earnings report revealed a missed EPS estimate of $1.10 compared to the expected $1.19, alongside a revenue increase of 3.3% year-over-year.
• Analysts have offered mixed ratings for Henry Schein, with a consensus average rating of "Hold" and a price target of $76.67.

Dark Forest Capital Management LP purchased a new stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the first quarter, according to its most recent filing with the SEC. The fund purchased 53,384 shares of the company's stock, valued at approximately $3,656,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of the stock. Farther Finance Advisors LLC increased its holdings in shares of Henry Schein by 237.3% in the 1st quarter. Farther Finance Advisors LLC now owns 2,698 shares of the company's stock worth $186,000 after buying an additional 1,898 shares during the last quarter. State of Alaska Department of Revenue boosted its position in Henry Schein by 2.8% in the 1st quarter. State of Alaska Department of Revenue now owns 14,611 shares of the company's stock valued at $1,000,000 after buying an additional 395 shares during the period. Oppenheimer Asset Management Inc. boosted its position in Henry Schein by 5.2% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 13,745 shares of the company's stock valued at $941,000 after buying an additional 678 shares during the period. GAMMA Investing LLC boosted its position in Henry Schein by 37.8% in the 1st quarter. GAMMA Investing LLC now owns 3,939 shares of the company's stock valued at $270,000 after buying an additional 1,081 shares during the period. Finally, Zuckerman Investment Group LLC boosted its position in Henry Schein by 69.6% in the 1st quarter. Zuckerman Investment Group LLC now owns 201,639 shares of the company's stock valued at $13,810,000 after buying an additional 82,779 shares during the period. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Stock Up 2.4%

Shares of NASDAQ:HSIC traded up $1.65 during trading hours on Friday, hitting $69.43. The company's stock had a trading volume of 1,360,668 shares, compared to its average volume of 1,598,436. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.78. The company has a market capitalization of $8.42 billion, a price-to-earnings ratio of 22.40, a P/E/G ratio of 2.29 and a beta of 0.86. The firm's fifty day moving average price is $69.92 and its 200 day moving average price is $69.74.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.09). The firm had revenue of $3.24 billion for the quarter, compared to the consensus estimate of $3.22 billion. Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The company's revenue was up 3.3% compared to the same quarter last year. During the same quarter last year, the firm earned $1.23 EPS. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. As a group, research analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current year.

Wall Street Analysts Forecast Growth

HSIC has been the subject of several research reports. UBS Group lowered their price objective on shares of Henry Schein from $75.00 to $70.00 and set a "neutral" rating for the company in a research report on Wednesday, August 6th. Wall Street Zen cut shares of Henry Schein from a "buy" rating to a "hold" rating in a research report on Sunday. Baird R W cut shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 14th. Evercore ISI raised shares of Henry Schein from an "in-line" rating to an "outperform" rating and set a $83.00 price objective for the company in a research report on Tuesday, August 26th. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Henry Schein from $80.00 to $76.00 and set an "overweight" rating for the company in a research report on Thursday, August 7th. Five analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $76.67.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.